The functional role of glomerular parietal epithelial cells (PECs) remains poorly understood. To test the hypothesis that PECs form an impermeable barrier to filtered protein through the formation of tight junctions (TJ), studies were performed in normal animals and in the anti-glomerular basement membrane (GBM) model of crescentic nephritis. Electron microscopy showed well-defined TJ between PECs in normal mice, which no longer could be identified when these cells became extensively damaged or detached from their underlying Bowman's basement membrane. The TJ proteins claudin-1, zonula occludens-1, and occludin stained positive in PECs; however, staining decreased in anti-GBM disease. To show that these events were associated with increased permeability across the PEC-Bowman's basement membrane barrier, control and diseased animals were injected intravenously with either Texas red-conjugated dextran (3 kDa) or ovalbumin (45 kDa) tracers. As expected, both tracers were readily filtered across the glomerular filtration barrier and taken up by proximal tubular cells. However, when the glomerular filtration barrier was injured in anti-GBM disease, tracers were taken up by podocytes and PECs. Moreover, tracers were also detected between PECs and the underlying Bowman's basement membrane, and in many instances were detected in the extraglomerular space. We propose that together with its underlying
PECs are attached to Bowman's basement membrane. Electron microscopic studies of Bowman's capsule from Taugner et al. (12) have shown features consistent with intercellular tight junctions. Tight junctions typically form an impermeable barrier between adjacent epithelial cells, which prevents the passage of ions and molecules between cells. They also define the apical and basal polarity of a cell and maintain the subcellular localization of proteins and lipids within appropriate compartments (4) . Tight junctions among epithelia in kidney have been studied extensively, yet tight junctions in PECs are not well described (7) . We recently reported that cultured mouse PECs and their in vivo counterparts express claudin-1, a tight junction protein (8) . This raises the possibility that PECs and the underlying Bowman's basement membrane may serve as a barrier to proteins and other ultrafiltrate constituents present in Bowman's space, thereby preventing their "escape" from the intraglomerular compartment to the extraglomerular compartment. The current studies were designed to test this possibility.
METHODS
Immunostaining of kidney sections. Indirect immunoperoxidase staining was performed on 4-m-thick sections from neutralized formalin-fixed, paraffin-embedded renal biopsies as previously reported (8) .
In brief, paraffin was removed with Histoclear (National Diagnostics, Atlanta, GA), and sections were rehydrated in ethanol. Antigen retrieval was performed by boiling sections in 10 mM citric acid buffer, pH 7.0 for Texas red, 1 mM EDTA, pH 8.0 for claudin-1 and Texas-red (for double staining), or 1 mM EDTA, pH 6.0 for PAX-8, as well as by enzyme digestion with protease XIV (Sigma-Aldrich, St. Louis, MO) as recommended by the manufacturer for zonula occludens-1 (ZO-1) and occludin. Endogenous peroxidase activity was quenched with 3% hydrogen peroxide, and nonspecific protein binding was blocked with Background Buster (Accurate Chemical and Scientific, Westbury, NY). Endogenous biotin activity was quenched with an avidin/biotin blocking kit (Vector Laboratories, Burlingame, CA). After blocking, tissue sections were incubated with the primary antibodies listed in the supplemental information overnight at 4°C (all supplemental material for this article is available on the journal web site). The appropriate biotinylated secondary antibodies anti-rabbit IgG (Vector Laboratories) were applied followed using an R.T.U. Vectastain kit (Vector Laboratories). Staining was visualized by precipitation of diaminobenzidine (DAB; Sigma-Aldrich).
Double staining for claudin-1 and Texas red was performed by staining first for claudin-1 followed by Texas red. As both primary antibodies were developed in rabbits, we performed blocking of the first secondary antibody with nonspecific rabbit IgG (Abcam, Cambridge, MA) and by blocking the reactive site of this nonspecific rabbit IgG with an anti-rabbit IgG Fab fragment (Jackson ImmunoResearch Laboratories, West Grove, PA). Biotin and peroxidase activity derived from the claudin-1 staining was blocked as described above following DAB. To visualize the Texas red signal, Vector SG (Vector Laboratories) was used as suggested by the manufacturer's instructions.
Two-micrometer-thick sections were used for periodic acid-methenamine silver stains according to standard protocols.
Animal studies. To clarify the expression of tight junction proteins in developing kidneys, embryonic kidneys of gestational day 21 (E21) were harvested from gravid C57/BL6 mice. All kidneys were fixed in neutralized formalin for immunohistochemistry. To measure changes in the level of specific tight junction proteins in PECs following injury, the following animal model was utilized. Sheep anti-rabbit glomeruli, antibody-induced experimental crescentic glomerulonephritis was produced as previously published (9) . Briefly, a polyclonal antibody was produced by immunizing sheep with whole rabbit glomeruli. Antiserum was heat inactivated, and IgG was isolated using caprylic acid precipitation of serum proteins. Experimental crescentic glomerulonephritis was induced in Balb/c mice (Charles River Laboratories, Wilmington, MA) by intraperitoneal injection of a sheep anti-rabbit glomerular basement membrane (GBM) antibody (15 mg/20 g body wt). Mice were killed at days 7, 9, and 14. The experimental protocols were approved by the University of Washington Animal Care Committee (5). All animal procedures were conducted in accordance with the Institutional Animal Care and Use Committee.
In vivo permeability assay. To prove that the glomerular ultrafiltrate containing protein escaped beyond the barrier imposed by PECs and the underlying Bowman's basement membrane, we established an in vivo permeability assay using specific tracers. For the anti-GBM nephritis mouse model, 9 days after the disease induction, two types of tracers were injected into disease and control mice. Control mice received nonpathogenic sheep IgG instead of nephrotoxic serum. Texas red (625 Da) was conjugated to either dextran (3 kDa) or ovalbumin (45 kDa; Invitrogen, Carlsbad, CA) as tracers. These two tracers were employed because their molecular weights are less than albumin and therefore could pass the slit diaphragm even in normal (nondisease) conditions. These tracers were considered to be the best materials to demonstrate the barrier function of PECs and to determine whether the distribution was limited by Bowman's capsule or if any leakage could evident around glomeruli. Dextran was reconstituted in PBS, and 0.5 mg dextran in 200 l PBS was injected intravenously into disease or control mice 9 days after they received pathogenic or nonpathogenic IgG, respectively. Ovalbumin was reconstituted in PBS, and 0.4 mg ovalbumin in 200 l PBS was injected into different sets of disease or control mice 9 days after the received pathogenic or nonpathogenic IgG, respectively. The injection of tracers was performed slowly and gently so that injecting pressure would not affect on the dynamics of filtration in glomeruli. Four mice with anti-GBM nephritis mice and two control mice were tested for each tracer. One minute after tracer injection, the kidneys were removed, cut in half, and fixed in neutral formalin overnight followed by processing and paraffin embedding. Because "fixable" dextran and the protein ovalbumin were utilized in this study, both types of tracers were fixed by formalin in this process. Therefore, tracers distributed within the kidney were detected by immunostaining with anti-Texas red antibody as described above.
Electron microscopy, immunoelectron microscopy. Tissue fixed in half-strength Karnovsky's solution was processed, embedded, stained, and examined according to standard protocols as previously published (11) .
Cell culture of mPECs and podocytes. A conditionally immortalized mouse PEC cell line (mPEC) and a podocyte cell line were also used for study. These have been previously established and characterized (8) . In brief, to generate mPECs and podocytes in culture, we utilized H-2Kb-tsA58 mice, also called Immortomice (Jackson Laboratory, Bar Harbor, ME). These mice harbor interferon-␥-inducible promoter for expression of thermosensitive SV40 large T antigen. Glomeruli were isolated from kidneys, and PECs were isolated from the outgrowths of glomeruli with Bowman's capsule, containing PECs and Bowman's basement membrane, while podocytes were isolated from glomeruli without Bowman's capsule by dilution cloning. PECs and podocytes were identified by confirming the presence of specific proteins by immunostaining and Western blotting. Cells were initially cultured under growth permission conditions on collagen I-coated plates at 33°C in the presence of IFN-␥ (50 U/ml). To induce the development of the differentiated phenotype, mirroring the in vivo PEC phenotype, cells were switched to 37°C without interferon-␥ for Ͼ12 days, which results in expression of the PEC-specific proteins. Cells were grown in RPMI 1640 media (Fisher) containing 5% (for mPEC) or 10% (for podocyte) FBS (Summit Biotechnology, Ft. Collins, CO), penicillin (100 U/ml), streptomycin (100 mg/ml), sodium pyruvate (1 mmol/l, Irvine Scientific, Santa Ana, CA), and 50 U/ml IFN-␥ (Roche Molecular Biochemicals, Indianapolis, IN).
Western blot analysis. To evaluate claudin-1 expression in podocytes, Western blot analysis was performed to analyze the expression levels of claudin-1 proteins. mPECs were used as a positive control for claudin-1 Western blotting. Cells were suspended in RIPA buffer (50 mM Tris ⅐ HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100, 1% NP-40), containing a proteinase inhibitor cocktail (Roche Molecular Biochemicals) with 1 mM sodium orthovanadate. Lysates were cleared by centrifugation, and protein concentrations were determined with a BCA protein assay kit (Pierce Biotechnology, Rockford, IL) according to the manufacturer's protocol. Reduced protein samples (10 g) were electrophoresed on 12% SDS-polyacrylamide gel and subsequently transferred to polyvinylidine difluoride membranes (Hybond-P). After blocking for 30 min with 5% nonfat dry milk, membranes were incubated overnight (4°C) with claudin-1 primary antibody (Invitrogen). Following washing in Tris-buffered saline containing 0.1% Tween 20 (TBS-T), membranes were incubated with biotinylated anti-rabbit IgG (GE Healthcare Bio-Sciences, Piscataway, NJ). Bands were visualized with ECLplus detection reagent (GE Healthcare Bio-Sciences), and membranes were exposed to Classic Blue autoradiography film BX (MidSci, St. Louis, MO) and developed. Then, the membrane was stripped once and Western blot analysis was repeated using a GAPDH antibody (Abcam).
RT-PCR. To further examine the expression of claudin-1 in podocytes, RT-PCR was also performed to determine the mRNA expression of claudin-1 in PECs and podocytes. Total RNA was isolated from the cells cultured under growth-restrictive conditions for 14 days using TRIzol (Invitrogen) according to the manufacturer's protocol. cDNA was synthesized using the oligo (dT) protocol contained in a First Strand cDNA Synthesis Kit (Fermentas, Hanover, MD). cDNA was amplified using primer sets specific for the mouse genes as follows: claudin-1 forward primer 5Ј-AGCCAGGAGCCTCGCCCCGCAGCTGCA-3Ј, claudin-1 reverse primer 5Ј-CGGGTTGCCTGCAAAGT-3Ј (ref); and GAPDH forward primer 5Ј-ACTGGTGTCTTCACCACCATGGAG-3Ј, GAPDH reverse primer 5Ј-ACACGGAAGGCCATGCCAGT-GAGC-3Ј.
Negative controls consisted of omitting reverse transcriptase and substituting this with water. The PCR reactions were performed as follows: 94°C for 5 min, followed by 33 cycles of 94°C for 1 min, 52 or 59°C for 1 min, and 72°C for 1 min. PCR products were separated on 2.0% ethidium bromide-stained agarose gels.
RESULTS

Expression of tight junction proteins in developing embryonic mouse kidney.
To determine the glomerular expression of tight junction proteins during development, and to specifically determine any differences in expression between PECs and podocytes, the expression and distribution of tight junction proteins were examined at different stages of glomerulogenesis in developing mouse glomeruli, and the results are shown in Fig. 1 . Claudin-1 staining was present in both PECs and podocytes during the S-shaped body stage. Staining was more abundant in both cell types during the capillary loop stage. In contrast, in mature glomeruli, claudin-1 staining was not detected in podocytes and was restricted to PECs. As PECs acquired a more flattened and mature phenotype, claudin-1 staining became more linear. Faint linear staining for ZO-1 was present from the late S-shaped body stage in both PECs and podocytes, and the staining intensity increased during the capillary loop stage. ZO-1 staining in PECs was restricted to cell-cell junctions. Occludin staining was first detected in PECs in the early capillary loop stage and persisted in the mature adult glomerulus (results not shown). PAX8 is the last isolated member of the paired box protein family and functions as a transcription factor that is involved in renal embryogenesis (10) . PAX8 is a marker of immature podocytes and PECs. The staining of PAX8, which is more specific to PECs in mature glomeruli, is shown only to better orient the reader to the location of PECs and immature podocytes during their various stages of glomerular development (Fig. 1, K-N) . The expression of tight junction proteins analyzed are summarized in Table 1 .
PECs stain positive for specific tight junction proteins in adult glomeruli. To establish whether PECs form an epithelial barrier through the formation of tight junctions between adjacent PECs, the expression of several tight junctions proteins was evaluated in adult glomeruli, and the results are shown in Fig. 2 . Claudin-1 staining localized specifically to PECs in normal mouse, rat, and human glomeruli and was present in a continuous pattern (Fig. 2, A-C) . As expected, claudin-1 staining was present in distal tubular epithelial cells, used as an internal positive control. Staining was absent when the primary antibody was omitted.
To further confirm the immunostaining of claudin-1 in PECs, Western blotting and RT-PCR were performed using cultured mouse PECs and podocytes. Podocytes showed only a very faint band for claudin-1. In contrast, mPECs showed an intense band at the predicted molecular weight (22 kDa, Supplemental Fig. 1A ). This result was consistent with our report published previously (8) . Furthermore, RT-PCR showed no band for claudin-1 in cultured podocytes; and mPECs showed an intense band at the predicted product size (397 bp, Supplemental Fig. 1B ). Taken together, glomerular expression of claudin-1 is predominantly in the PECs with minimal expression in the podocytes.
Claudin-2 immunostaining was also detected in PECs in normal mice (data not shown), as well as in other kidney cells. The staining pattern was linear along Bowman's basement membrane in normal mouse and rat glomeruli.
ZO-1 staining was detected in mouse, rat and human PECs, and this was restricted to cell-cell junctions (Fig. 2, D-I) . This was not a false positive, because ZO-1 staining was absent when the primary antibody was omitted. ZO-1 staining in podocytes served as a positive control.
Immunostaining for the tight junction protein occludin was present in PECs in normal mouse, rat, and human glomeruli; however, staining was fainter in rat and mouse compared with human glomeruli (Fig. 2, J-O) . Occludin staining was also detected in the glomerular tuft; however, the staining showed a "speckled" pattern in PECs and was linear in the glomerular tuft.
Changes in PEC tight junction proteins during experimental glomerular disease. To investigate changes in tight junction proteins during disease, immunostaining was performed in the anti-GBM mouse model of nephritis, and the results are shown in Fig. 3 . Claudin-1 staining decreased in PECs 9 days after disease induction specifically in glomeruli with evidence of injury, such as crescent formation and/or glomerulosclerosis. Claudin-1 staining was detected, albeit much more weakly, within cellular crescents composed mostly of proliferating, multilayered PECs (Fig. 3, A-D) . ZO-1 staining also decreased in PECs in experimental anti-GBM disease in areas with histological evidence of injury, especially in areas with crescent formation (Fig. 3, E and F) . Occludin staining was also decreased in PECs in diseased glomeruli (Fig. 3, G and H) . No staining was present when the primary antibody was omitted (Fig. 3, I and J) .
Ultrastructure of PECs in normal and disease states. In normal glomeruli, PECs appeared as slender cells, often without a detectable nucleus. Adjacent PECs overlapped, forming a junctional structure at their cell borders. Tight junctions were detected at the apical side of overlapping PECs (Fig. 4A) . In diseased animals, the cell membranes of PECs were destroyed and some organelles were exposed to the urinary space. In less injured PECs, well-defined tight junctions were maintained, but there were increased distances between cells at the lateral borders (Fig. 4B) . This finding indicates that the tight junctions between these cells were detached.
No disruption of Bowman's basement membrane during experimental glomerular disease. To determine whether the basement membrane of Bowman's capsule was disrupted in injured glomeruli, silver staining was performed on kidney biopsies from control mice and mice with anti-GBM nephritis at days 7, 9, and 14 following disease induction. No ruptures in Bowman's basement membrane were detected at any time point in disease, even in glomeruli that were obviously injured (Fig. 5) . In some glomeruli, there was duplication of Bowman's basement membrane, which encircled PECs.
Tracers diffuse beyond PECs in experimental disease.
To test the hypothesis that PECs function as a barrier preventing glomerular ultrafiltrate constituents from exiting Bowman's space into the periglomerular interstitial space, a tracer approach was utilized to track the flow of glomerular ultrafiltrate in vivo. Two separate tracers with different molecular weights, but both small enough to readily pass through the glomerular filtration barrier under normal conditions, were given intravenously to normal mice and to mice with anti-GBM disease. The following tracers were used: 1) dextran (3 kDa) conjugated to Texas red and 2) ovalbumin (45 kDa) conjugated to Texas red. These tracers were specifically chosen because our feasibility studies in normal and control animals showed that when injected intravenously, both tracers were detected in the glomerular capillary loops (Fig. 6 ). Both tracers then cross the normal glomerular filtration barrier into the urinary space (Fig.  6, A and D) ; the smaller dextran tracer crossed more readily than the larger ovalbumin. Tracers were then taken up by proximal tubular cells (Fig. 6, A and D) . Also, the smaller dextran tracer showed positive signals within podocytes, which suggests this size of dextran was taken up by podocyte in control conditions (Fig. 6A) .
The staining for the smaller dextran tracer in animals with experimental anti-GBM disease is shown in Fig. 6 , B and C. We identified the following "stages" as judged by Texas red staining.
Stage 1: normal staining within glomerular capillary loops, similar to control, nondiseased animals.
Stage 2: staining within podocyte cell bodies (Fig. 6B) . Stage 3: staining within PEC cell bodies (Fig. 6C ).
Stage 4: staining between the PEC and Bowman's basement membrane (Fig. 6B) .
Stage 5: staining between cell layers within glomerular crescents (Fig. 6C) .
Stage 6: staining in the extraglomerular space (Fig. 6, B and C) . Figure 6E shows that stage 6 (extraglomerular) staining was also detected when diseased animals were injected with ovalbumin.
At stage 6, distribution of tracers into the extraglomerular space was one of the most important findings in the current study, and thus more images of stage 6 staining are shown in Fig. 6 , G-N. High-magnification images (Fig. 6, J, L, and N) show representative images of tracers in the extraglomerular space where multiple cellular layers were always formed and tracers were stained in between these layers. Neither cellular layers nor positive tracer staining was found in the extraglomerular space in control mice (Fig. 6, G and H) .
To further clarify the relationship between misdirected urinary flow (as in stages 4 -6) and the expression of claudin-1, double staining for claudin-1 and Texas red was performed. As shown in Fig. 7 , extraglomerular staining for dextran (Texas red staining) often corresponded to faint and irregular staining for claudin-1 in PECs. These results suggest that the decrease in the tight junction protein claudin-1 was associated with the loss of the normal barrier function of PECs to glomerular ultrafiltrate.
DISCUSSION
The biological functions of PECs are poorly understood in health, as are the consequences of these during disease. The data presented in this manuscript are consistent with the presence of tight junctions between PECs and with the hypothesis that an important function of PECs is to restrict protein in the glomerular ultrafiltrate to the confines of Bowman's space, thereby preventing protein from passing into the extraglomerular space.
A major finding in these studies was that tight junctions are normally present between PECs, and these are characterized by the presence of several tight junction proteins. The electron Fig. 5 . Silver staining of anti-GBM nephritis mouse. Silver staining was performed to visualize any defects in BBM in the mouse anti-GBM nephritis model. Compared with control mice (A), the pattern of silver staining of the BBM was indistinguishable from anti-GBM disease at days 7, 9, and 14 (B-D). In D, the BBM was duplicated in some segments of glomeruli at day 14, "engulfing" PECs. microscopic data clearly show that classic tight junctions are present between adjacent PECs in normal glomeruli. Accordingly, tight junction protein expression by PECs was delineated and their temporal relationship during kidney development was examined. Claudin-1 staining was positive from the S-phase onward in both PECs and podocytes but persisted in mature PECs only. ZO-1 staining was first detected in both cell types in the S-phase, with increased staining intensity noted during the capillary loop phase. Staining for ZO-1 persisted in the normal adult PEC and podocyte. Occludin and claudin-2 staining was also present in mature PECs. These data show differential expression of TJ proteins in normal PECs and podocytes. Taken together, these data are consistent with the notion that PECs express tight junction proteins and assemble tight junctions.
The second finding in this study was the alterations in tight junction proteins immunohistochemically following injury in experimental glomerular disease. Tight junctions between cells without ultrastructural alterations were maintained. Tight junctions were no longer identifiable in cells with extensive disruption and were not apparent where cells had become detached from the underlying basement membranes.
Results also showed substantial decreases in immunostaining for claudin-1, ZO-1, and occludin in PECs in experimental anti-GBM disease. Moreover, these decreases preceded the presence of glomerular crescents. We next asked what the biological significance was of the decreased levels of PEC tight junction proteins. Given that PECs adhere to the underlying Bowman's basement membrane, we proposed that PEC-Bowman's basement membrane exhibit a barrier function and that this is in part served by the presence of PEC tight junctions. To prove this, we developed an in vivo permeability assay by intravenously injecting two labeled tracers of different molecular weights to normal and diseased animals. The third major finding in this study was that when injected intravenously, both smaller-sized tracers (3 kDa) and larger-sized tracers (45 kDa) pass from the glomerular capillary lumen into the urinary space in normal mice. As expected, tracers were then taken up by proximal tubular cells; however, no tracer was detected in the extraglomerular space. Interestingly, the smaller dextran (3 kDa) was taken up by podocytes in normal mice without disease, but ovalbumin (45 kDa) was not. We did not study the reasons underlying these differences in uptake by podocytes under normal conditions but offer two speculative explanations. One is that the smallersized particles (3 kDa) may simply diffuse into podocytes once they pass through the endothelium and GBM. Two, there may be differences in the kinetics of sugar (dextran) uptake vs. protein (ovalbumin) uptake.
The data showed interesting patterns for both tracers in experimental anti-GBM disease. The primary injury to the GBM in this model of anti-GBM nephritis causes proteinuria, consistent with a defect in the glomerular filtration barrier. Although the GBM is the target of the antibody, the glomerular endothelial cells and podocytes are likely injured secondarily. Thus as expected, the defect(s) in one or more of these barriers to proteinuria was associated with increased passage of intravenously injected tracers across the glomerular filtration barrier. However, we observed several different patterns of tracer uptake in diseased animals not present in control animals, which we described simply as "stages" based on anatomic definitions starting from the glomerular tuft outward. Note that not every glomerulus showed all stages at any one time. The tracer in stage 1 was confined to the blood space in the intraglomerular capillaries. Stage 2 was characterized by marked uptake of tracer by podocytes. Akilesh and colleagues (1) have previously shown endocytosis by podocytes. Further from the glomerular tuft we detected tracer uptake by PECs, which was not detected in normal or control animals (stage 3). The tracer was confined to the PEC cytoplasm, consistent with uptake by an as yet undefined endocytosis mechanism. Stage 4 represents the presence of tracer between the PEC and the underlying Bowman's basement membrane. This was consistent with the notion that tracer either passed through the tight junctions and/or was taken up by PECs and "deposited" on the basal surface. When crescents were present, tracer was evident between cell layers in cellular crescents (stage 5). Finally, tracer was detected beyond the glomerulus in the extraglomerular space (stage 6). In the absence of detecting any breaks in Bowman's basement membrane during this early phase either by silver staining or electron microscopy, we propose that this is because of a primary defect in the PEC, and then the threshold of resistance imposed by the basement membrane is breached. An alternate mechanism could be that tracer was taken up by proximal tubules and then deposited outside of the cell on the apical surface.
One may ask why PECs are injured in the anti-GBM nephritis model? Given that the disease-inducing antibody does A: in the control mice, claudin-1 (brown) was expressed in PECs in a linear pattern, and no extraglomerular dextran was observed (blue). B: in mice with anti-GBM nephritis, less claudin-1 staining was observed (brown) near areas with extraglomerular staining for dextran (blue, arrows). not bind to PECs or Bowman's basement membrane, it is likely a secondary response, similar to what happens following glomerular endothelial cell injury in ANCA-induced vasculitis. Possibilities whereby PECs are injured in this disease include secondary injury induced by cytokines and/or inflammatory factors released by injured podocytes. Another possibility is that increased proteinuria is itself injurious to PECs. Further delineation of these possibilities is warranted.
Based on the data presented here, we propose the following model ( Fig. 8): whenever there is increased permeability of the glomerular filtration barrier (due to injury to either the endothelial cell, GBM, and/or podocyte), the increased filtered protein (represented here by tracer) is handled by various mechanisms, including uptake by podocytes, PECs, and proximal tubular cells. We propose that when PECs are injured, and the morphology and proteins of the tight junction are abnormal, the usual barrier to permeability no longer functions, and protein escapes into the extraglomerular space. This and other factors from within the glomerulus initiate an inflammatory response, recognized as periglomerular inflammation and ultimately fibrosis. This is different from the misdirected filtration model demonstrated by Kriz et al. (6) . In his model, there is misdirected filtration in the setting of the synechia, which directs urine between the layers of the tubular basement membrane and tubular cells at the urinary pole of the glomerulus. While the PEC is involved in the process, because it is separated by the synechia from Bowman's basement membrane, it is the synechia itself which causes the misdirected filtration, not a loss of the tight junctions in PECs (6) .
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